programmed cell death 5 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored PDCD5P1 profile across patient tissues and cancer cell-line models. PDCD5P1 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in MESO. Among the 18 cancer types available for tumor–normal comparison, PDCD5P1 is differentially expressed in 11, with the highest sampling consensus in COAD. Additionally, PDCD5P1 RNA expression shows 11,217 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight MESO, COAD, and TGCT as cancer lineages where PDCD5P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for PDCD5P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes PDCD5P1 survival associations across molecular data types. PDCD5P1 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible PDCD5P1 RNA expression–survival associations across cancer types. High PDCD5P1 expression shows unfavorable associations in MESO, STAD, LIHC, KICH and BRCA, but favorable associations in LUSC. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify MESO as the clearest survival context for PDCD5P1 RNA expression.
This table summarizes PDCD5P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for PDCD5P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. PDCD5P1 shows higher tumor expression in COAD, HNSC, BLCA, UCEC, LUSC and KIRC. The COAD box plot shows higher PDCD5P1 RNA expression in tumor versus normal tissue (log2 FC = +1.035, t-test p < 0.001).
This table shows molecular features associated with PDCD5P1 in patient tissues and cancer cell lines. In patient samples, PDCD5P1 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
